The Burn Centre is the only specialised facility managing major burn injuries in Southeast Asia, committed to providing the best medical therapy to patients. The Burns Centre is run by a dedicated team of health care providers including doctors, nurses, physiotherapists, occupational therapists, nutritionists, medical social workers and other ancillary staff. Together, they look after burn patients from the point of injury to their post-hospital rehabilitative period.
The Burn Centre follows a strict admission criteria, and will only accept patients requiring specialised care including those that suffer from:
The SGH Burn Centre is a tertiary referral facility and will only accept burned patients requiring specialised care, and these are confined to patients with the following injuries :
The Burn Centre admits patients through the following sources :
Singapore General Hospital, Block 4 Level 3
Monday to Friday: 8.00am to 6.00pm Saturday:
8.00am to 1.00pm
Sunday and Public Holiday: Closed
Tel: 6321 4430
Fax: 6321 3890
The entire Centre is fully air-conditioned with the ventilation system comprising twenty air-changes an hour. This controlled environment which simulates an Operating Theatre environment is aimed at reducing levels of ambient airborne organisms thereby reducing cross-contamination of burns wounds with airborne organisms. A special viewing corridor outside the unit allows the patients in the isolation rooms to be in visual contact with their relatives without coming into direct physical contact.
The Centre is divided into two wings to facilitate cohort nursing. 6 beds are devoted to critically-ill patients, and 10 beds are set aside for patients requiring intermediate care in a high-dependency area. Separate areas are set aside for dressings change, physiotherapy and convalescence, and an area for paediatric patients.
A self-sufficient operating theatre enables all primary wound excision and skin grafting procedures to be performed within the Centre. Patients requiring secondary reconstructive procedures are not admitted to the Burn Centre and therefore secondary reconstructive procedures are generally not performed here. The utilization of this operating theatre situated within the Burn Centre has facilitated the ease of transfer of these major burns patients from their rooms to the theatre (the main hospital operating theatre is located some distance away on another floor). Ease of transfer of patients minimize the potential dangers of transport of the critically-ill, the main ones being airway disconnection and discontinuity in monitoring. In addition, theatre scrub personnel dedicated to burns surgery has also greatly expedited the performance of the surgical procedures.
A cell culture laboratory within the Burn Centre dedicated to the culture and preparation of cultured epithelial autografts provides laboratory support for our skin culture project.
This clinical trial investigates the efficacy of Moist Exposed Burn Ointment in the management of mixed-thickness burns wounds as compared to conventional management with silver sulphadiazine. Outcome indicators include time for wound healing, resultant scar quality and use of analgesia. (NMRC/0125/1995).
The use of recombinant growth hormone has been investigated by several centres in the United States for patients with severe thermal injuries. Favourable results have been reported in terms of acceleration of donor site healing time and reduction of hospital stay. Our clinical trial will investigate the impact of recombinant growth hormone on donor site and grafted site healing, and morbidity in patients with major thermal injury.
Limited donor sites remain a major problem with patients sustaining large area burns. Integra artificial skin acts as a minimally-immunogenic biological dressing following excision of burn wounds and allows the use of thin split skin autografts which in turn means that donor sites can be re-cropped more frequently. Research efforts are also aimed at combining Integra with cultured epithelial autograft.
Together with the Department of Clinical Research of SGH, we have been actively involved in research into expediting the growth and take of cultured epithelial cells including use of fibrin glue and other techniques. Research is also being carried out in the use of lyophilised amniotic membrane.
The Singapore General Hospital's (SGH) Skin Bank/Skin Culture Laboratory was set up in 1991 to meet the skin graft needs for the treatment of patients with severe burns.
The Burns Centre at Singapore General Hospital
New Burns Protocol Speeds Up Skin Recovery with Fewer Complications and Shortens Hospital Stay for Burns Patients, SGH Latest Study Shows
Stay Healthy With
© 2025 SingHealth Group. All Rights Reserved.